ConductScience.org, home

Paper14198243

STUDIES WITH THE MURINE LEUKEMOGENIC RAUSCHER VIRUS. 3. AN IN VIVO ASSAY FOR ANTI-VIRAL AGENTS.

CHIRIGOS MA. Cancer Res, 1964. Cited by 61 papers, by iCite.

Cite this record

ConductScience Library. STUDIES WITH THE MURINE LEUKEMOGENIC RAUSCHER VIRUS. 3. AN IN VIVO ASSAY FOR ANTI-VIRAL AGENTS. Papers, record 14198243. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/14198243

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
STUDIES WITH THE MURINE LEUKEMOGENIC RAUSCHER VIRUS. 3. AN IN VIVO ASSAY FOR ANTI-VIRAL AGENTS.
PubMed
Journal
Cancer Res
PubMed
Year
1964
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
61
iCite
Revised in PubMed
2026-10-14
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1CHIRIGOS MAM A

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic AgentsMajor topic
Antiviral AgentsMajor topic
Biological AssayMajor topic
CyclophosphamideMajor topic
MercaptopurineMajor topic
MethotrexateMajor topic
Oncogenic VirusesMajor topic
PharmacologyMajor topic
PrednisoneMajor topic
Rauscher VirusMajor topic
ResearchMajor topic
SplenomegalyMajor topic
Animals
Mice

Source PubMed

Download CSV of topics

Cited by9

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 61 citations.

PMIDTitleJournalYearIn PapersSource
15825311Antivirion effects of streptovaricin complex against Friend virus.Antimicrob Agents Chemother1974https://conductscience.org/library/papers/15825311PubMed
14339266IN VIVO ANTIVIRAL ACTIVITY OF 1,3-BIS(2-CHLOROETHYL)-1-NITROSOUREA.Appl Microbiol1965https://conductscience.org/library/papers/14339266PubMed
8723481Comparative kinetic analyses of interaction of inhibitors with Rauscher murine leukemia virus and human immunodeficiency virus reverse transcriptases.Antimicrob Agents Chemother1996https://conductscience.org/library/papers/8723481PubMed
6796284Changes in toxic and antitumor properties of ftorafur by induction or inhibition of the microsomal enzymes activity.Cancer Chemother Pharmacol1981https://conductscience.org/library/papers/6796284PubMed
6035050Purification of the Moloney and Rauscher murine leukemia viruses by use of zonal ultracentrifuge systems.Appl Microbiol1967https://conductscience.org/library/papers/6035050PubMed
5456940Recovery of Rauscher leukemia virus from large volumes of seeded cow's milk and from infected murine spleens.Appl Microbiol1970https://conductscience.org/library/papers/5456940PubMed
4123070RNA-directed DNA polymerase and virus-induced leukemia in mice.Proc Natl Acad Sci U S A1973https://conductscience.org/library/papers/4123070PubMed
2415971Suppression of retroviral propagation and disease by suramin in murine systems.Proc Natl Acad Sci U S A1985https://conductscience.org/library/papers/2415971PubMed
2371289Vaccination with a live retrovirus: the nature of the protective immune response.Proc Natl Acad Sci U S A1990https://conductscience.org/library/papers/2371289PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/14198243

GET https://conductscience.org/api/papers/v1/14198243/authors